100% of mice treated with a single intravenous dose of VV169 saw complete clearance of disseminated myeloma tumors within 28 days Another dataset...

100% of mice treated with a single intravenous dose of VV169 saw complete clearance of disseminated myeloma tumors within 28 days Another dataset...

Human intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity and specialized machinery...

One of the most exciting advances in cancer treatments over the past decade is the development of T cell immunotherapies, in which a patient’s own...

One of the most exciting advances in cancer treatments over the past decade is the development of T cell immunotherapies, in which a patient’s own...

Recent advancements in cancer vaccine development have demonstrated their potential for precise tumor targeting through antigen-specific immune...

Researchers at Mass General Brigham, USA, have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells....

Australian researchers have discovered a molecular ‘safety switch’ which shields cancer cells from immune system attacks and limits the...

Australian researchers have discovered a molecular ‘safety switch’ which shields cancer cells from immune system attacks and limits the...

HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...